104 related articles for article (PubMed ID: 17956457)
1. Urinary excretion of inositol phosphoglycan P-type in gestational diabetes mellitus.
Scioscia M; Kunjara S; Gumaa K; McLean P; Rodeck CH; Rademacher TW
Diabet Med; 2007 Nov; 24(11):1300-4. PubMed ID: 17956457
[TBL] [Abstract][Full Text] [Related]
2. Altered urinary release of inositol phosphoglycan A-type in women with gestational diabetes mellitus.
Scioscia M; Kunjara S; Gumaa K; Gomez Galan AM; McLean P; Rodeck CH; Rademacher TW
Gynecol Obstet Invest; 2007; 64(4):217-23. PubMed ID: 17664885
[TBL] [Abstract][Full Text] [Related]
3. Increased inositol phosphoglycan P-type in the second trimester in pregnant women with type 2 and gestational diabetes mellitus.
Scioscia M; Gumaa K; Selvaggi LE; Rodeck CH; Rademacher TW
J Perinat Med; 2009; 37(5):469-71. PubMed ID: 19492925
[TBL] [Abstract][Full Text] [Related]
4. Inositol phosphoglycans and signal transduction systems in pregnancy in preeclampsia and diabetes: evidence for a significant regulatory role in preeclampsia at placental and systemic levels.
Kunjara S; Greenbaum AL; Wang DY; Caro HN; McLean P; Redman CW; Rademacher TW
Mol Genet Metab; 2000 Feb; 69(2):144-58. PubMed ID: 10720442
[TBL] [Abstract][Full Text] [Related]
5. Inositol phosphoglycan P-type in infants of preeclamptic mothers.
Scioscia M; Robillard PY; Hall DR; Rademacher LH; Williams PJ; Rademacher TW
J Matern Fetal Neonatal Med; 2012 Feb; 25(2):193-5. PubMed ID: 21401313
[TBL] [Abstract][Full Text] [Related]
6. Inositol phosphoglycan putative insulin mediator in human amniotic fluid.
Scioscia M; Vimercati A; Selvaggi LE; Rodeck CH; Rademacher TW
J Matern Fetal Neonatal Med; 2006 Jan; 19(1):9-12. PubMed ID: 16492584
[TBL] [Abstract][Full Text] [Related]
7. Release of inositol phosphoglycan P-type by the human placenta following insulin stimulus: a multiple comparison between preeclampsia, intrauterine growth restriction, and gestational hypertension.
Scioscia M; Paine MA; Gumaa K; Rodeck CH; Rademacher TW
J Matern Fetal Neonatal Med; 2008 Aug; 21(8):581-5. PubMed ID: 18609357
[TBL] [Abstract][Full Text] [Related]
8. Using the 100-g oral glucose tolerance test to predict fetal and maternal outcomes in women with gestational diabetes mellitus.
Lin CH; Wen SF; Wu YH; Huang MJ
Chang Gung Med J; 2009; 32(3):283-9. PubMed ID: 19527607
[TBL] [Abstract][Full Text] [Related]
9. Urinary inositol phosphoglycan P-type as a marker for prediction of preeclampsia and novel implications for the pathophysiology of this disorder.
Paine MA; Scioscia M; Williams PJ; Gumaa K; Rodeck CH; Rademacher TW
Hypertens Pregnancy; 2010; 29(4):375-84. PubMed ID: 20701477
[TBL] [Abstract][Full Text] [Related]
10. P-type inositol phosphoglycans in serum and amniotic fluid in active pre-eclampsia.
Paine MA; Scioscia M; Gumaa KA; Rodeck CH; Rademacher TW
J Reprod Immunol; 2006 Apr; 69(2):165-79. PubMed ID: 16384607
[TBL] [Abstract][Full Text] [Related]
11. Inositol phosphoglycan P-type in healthy and preeclamptic pregnancies.
Scioscia M; Gumaa K; Whitten M; Selvaggi LE; Rodeck CH; Rademacher TW
J Reprod Immunol; 2007 Dec; 76(1-2):85-90. PubMed ID: 17493685
[TBL] [Abstract][Full Text] [Related]
12. Detection of pregnancies with high risk of fetal macrosomia among women with gestational diabetes mellitus.
Suhonen L; Hiilesmaa V; Kaaja R; Teramo K
Acta Obstet Gynecol Scand; 2008; 87(9):940-5. PubMed ID: 18728914
[TBL] [Abstract][Full Text] [Related]
13. Maternal and foetal resistin and adiponectin concentrations in normal and complicated pregnancies.
Cortelazzi D; Corbetta S; Ronzoni S; Pelle F; Marconi A; Cozzi V; Cetin I; Cortelazzi R; Beck-Peccoz P; Spada A
Clin Endocrinol (Oxf); 2007 Mar; 66(3):447-53. PubMed ID: 17302882
[TBL] [Abstract][Full Text] [Related]
14. The link between insulin resistance and preeclampsia: new perspectives.
Scioscia M; Gumaa K; Rademacher TW
J Reprod Immunol; 2009 Nov; 82(2):100-5. PubMed ID: 19628283
[TBL] [Abstract][Full Text] [Related]
15. Blood ketone monitoring: a comparison between gestational diabetes and non-diabetic pregnant women.
Gin H; Vambergue A; Vasseur C; Rigalleau V; Dufour P; Roques A; Romon M; Millet D; Hincker P; Fontaine P;
Diabetes Metab; 2006 Dec; 32(6):592-7. PubMed ID: 17296512
[TBL] [Abstract][Full Text] [Related]
16. Blood pressure and lipid changes in gestational diabetes mellitus.
Szymanska M; Bomba-Opon DA; Wielgos M
Neuro Endocrinol Lett; 2008 Jun; 29(3):328-33. PubMed ID: 18580853
[TBL] [Abstract][Full Text] [Related]
17. Total plasma homocysteine correlates in women with gestational diabetes.
Idzior-Waluś B; Cyganek K; Sztefko K; Seghieri G; Breschi MC; Waluś-Miarka M; Kawalec E; Seretny M; Sieradzki J
Arch Gynecol Obstet; 2008 Oct; 278(4):309-13. PubMed ID: 18236055
[TBL] [Abstract][Full Text] [Related]
18. Screening for gestational diabetes mellitus in Nigerian pregnant women using fifty-gram oral glucose challenge test.
Adegbola O; Ajayi GO
West Afr J Med; 2008 Jul; 27(3):139-43. PubMed ID: 19256316
[TBL] [Abstract][Full Text] [Related]
19. Placental weight and placental weight-to-birth weight ratio are increased in diet- and exercise-treated gestational diabetes mellitus subjects but not in subjects with one abnormal value on 100-g oral glucose tolerance test.
Kucuk M; Doymaz F
J Diabetes Complications; 2009; 23(1):25-31. PubMed ID: 18413216
[TBL] [Abstract][Full Text] [Related]
20. Reversal of type 2 diabetes in mice by products of malaria parasites. II. Role of inositol phosphoglycans (IPGs).
Elased KM; Gumaa KA; de Souza JB; Rahmoune H; Playfair JH; Rademacher TW
Mol Genet Metab; 2001 Jul; 73(3):248-58. PubMed ID: 11461192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
